Search research articles
Contact Us
Filters
Showing results (81-90 of 101) with videos related to
Page
of 11
Sort By:
Lancet (London, England)
|
October 28, 1989
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
J Bruix, J M Barrera, X Calvet, et al.
Radiologia
|
July 17, 2025
Transarterial chemoembolization with doxorubicin-loaded radiopaque beads for hepatocellular carcinoma: Safety, efficacy, and distribution
A Páez-Carpio, P Bermúdez, M Sanduzzi Zamparelli, et al.
Journal of Hepatology
|
October 6, 2000
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis
J M Llovet, E Moitinho, M Sala, et al.
Annals of Internal Medicine
|
June 15, 1990
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease
J M Sánchez-Tapias, J M Barrera, J Costa, et al.
Gastroenterologia Y Hepatologia
|
April 1, 1996
[Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis]
J I Elizalde, A Castells, R Planas, et al.
Journal of Hepatology
|
February 7, 1998
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
F X López-Labrador, S Ampurdanés, X Forns, et al.
Journal of Hepatology
|
August 29, 1998
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action
C Bréchot, F Jaffredo, D Lagorce, et al.
Hepatology (Baltimore, Md.)
|
May 9, 2001
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
J M Llovet, R Vilana, C Brú, et al.
Journal of Hepatology
|
July 16, 1999
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases
M Giménez-Barcons, X Forns, S Ampurdanés, et al.
British Journal of Cancer
|
January 5, 2013
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
A Santoro, M Simonelli, C Rodriguez-Lope, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 101) with videos related to
Sort By:
Page
of 11
Lancet (London, England)
|
October 28, 1989
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis
J Bruix, J M Barrera, X Calvet, et al.
Radiologia
|
July 17, 2025
Transarterial chemoembolization with doxorubicin-loaded radiopaque beads for hepatocellular carcinoma: Safety, efficacy, and distribution
A Páez-Carpio, P Bermúdez, M Sanduzzi Zamparelli, et al.
Journal of Hepatology
|
October 6, 2000
Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis
J M Llovet, E Moitinho, M Sala, et al.
Annals of Internal Medicine
|
June 15, 1990
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease
J M Sánchez-Tapias, J M Barrera, J Costa, et al.
Gastroenterologia Y Hepatologia
|
April 1, 1996
[Prevalence of hepatocellular carcinoma in cirrhotic patients with with portosystemic shunt. Cohort analysis]
J I Elizalde, A Castells, R Planas, et al.
Journal of Hepatology
|
February 7, 1998
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
F X López-Labrador, S Ampurdanés, X Forns, et al.
Journal of Hepatology
|
August 29, 1998
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action
C Bréchot, F Jaffredo, D Lagorce, et al.
Hepatology (Baltimore, Md.)
|
May 9, 2001
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
J M Llovet, R Vilana, C Brú, et al.
Journal of Hepatology
|
July 16, 1999
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases
M Giménez-Barcons, X Forns, S Ampurdanés, et al.
British Journal of Cancer
|
January 5, 2013
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
A Santoro, M Simonelli, C Rodriguez-Lope, et al.
Page
of 11